Company Filing History:
Years Active: 2015-2021
Title: Mamoru Otoyo: Innovator in Pharmaceutical Applications
Introduction
Mamoru Otoyo is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of proteins that target calcitonin gene-related peptide (CGRP). With a total of four patents to his name, Otoyo's work has the potential to impact therapeutic applications, especially in the treatment of migraines.
Latest Patents
Otoyo's latest patents focus on hNGAL muteins that bind CGRP. These muteins can be utilized in various pharmaceutical applications, including migraine treatment. The patents also detail methods for creating these muteins, as well as the nucleic acid molecules that encode them. Furthermore, the applications disclose therapeutic and diagnostic uses for these muteins, highlighting their versatility in medical science.
Career Highlights
Throughout his career, Mamoru Otoyo has worked with prominent companies in the pharmaceutical industry. He has been associated with Pieris Pharmaceuticals GmbH and Daiichi Sankyo Company, Limited. His experience in these organizations has contributed to his expertise in the development of innovative therapeutic solutions.
Collaborations
Otoyo has collaborated with several professionals in his field, including Ryuji Hashimoto and Gabriele Matschiner. These collaborations have likely enhanced his research and development efforts, leading to the successful creation of his patented inventions.
Conclusion
Mamoru Otoyo is a distinguished inventor whose work in the pharmaceutical sector has the potential to revolutionize treatments for conditions such as migraines. His innovative patents and collaborations reflect his commitment to advancing medical science.